Some studies report that platelet pretreatment with aspirin or a P2Y 12 inhibitor has minimal effect on the generation of procoagulant platelets and their thrombin-generating potential [59]
However, trial participants consistently lost weight while taking them, which prompted further research into their use for weight management
(Blaesse P, Goedecke L, Bazelot M, et al
on the DT Peptides blog.) Retatrutide Clinical Trial Results: How Much Weight Loss
Complementary Research Compounds for Broader Metabolic Research Design Retatrutide's triple-agonist mechanism engages GLP-1, GIP, and glucagon receptors, but the broader biology of metabolic dysfunction extends beyond the receptors Retatrutide directly activates
These are not the same measurement system, and converting between them requires knowing your vial concentration